Not Yet RecruitingNot Applicable

Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis

Bangladesh68 participantsStarted 2026-04-01

Plain-language summary

This randomized controlled trial evaluates the comparative effectiveness of platelet-rich plasma (PRP) therapy and prolotherapy in patients with plantar fasciitis. Both interventions are commonly used regenerative injection therapies intended to improve pain and functional outcomes in patients who do not respond adequately to conventional conservative treatments. Participants diagnosed with plantar fasciitis will be randomly assigned to receive either PRP injection or prolotherapy. The results of this study aim to identify the more effective injection therapy for improving clinical outcomes in patients with plantar fasciitis

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with plantar fasciitis not responding to conservative therapy. Exclusion Criteria: * Patients with uncontrolled diabetes, haematological disorders, hepatitis B or C, HIV, clinical signs of acute inflammation, or septicaemia. * Those receiving local steroid injections within one month. * Those receiving non-steroidal anti-inflammatory medications within 72 hours. * Platelet levels 25% below the normal level. * Patient who had acute ankle or foot trauma, a diagnosis of calcaneal fracture, or stress fracture.

What they're measuring

Pain intensity measured by the Visual Analog Scale (VAS)

Timeframe: Baseline, 2 weeks, 4 weeks, 3 months, 6 months

Trial details

NCT IDNCT07480967

SponsorBangladesh Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-31

Contact for this trial

Kazi Mahzabin Arin, MD

+8801754057689 kazimahzabinarin@bsmmu.edu.bd

View on ClinicalTrials.gov More Planter Fasciitis trials